Lymphatic invasion according to D2-40 immunostaining is a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus

Pathology International

Volumn 58, Issue 8, 2008, Pages 471-476

  Miyakuni, Yasuka ^a   Matsumoto, Toshiharu ^a   Arakawa, Atsushi ^a   Sonoue, Hiroshi ^a   Suzuki, Chikako ^a   Takeda, Satoru ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

D2 40 immunostaining; Endometrioid adenocarcinoma; Lymphatic invasion; Nodal metastasis; Uterine corpus

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UTERUS CARCINOMA;

ANTIBODIES, MONOCLONAL; CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 46749109656     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02258.x     Document Type: Article

References (16)

1. Sidawy MK, Silverberg SG. Endometrial carcinoma. Pathologic factors of therapeutic and prognostic significance. Pathol Annu 1992 27: 153 85.
2. Lee KR, Vacek PM, Belinson JL. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol 1994 54: 10 18.
3. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma. The importance of the distinction between surgical stage and clinical state: A Gynecologic Oncology Group study. Cancer 1996 77: 1115 21.
4. Inoue Y, Obata K, Abe K et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996 78: 1447 51.
5. Hachisuga T, Kaku T, Fukuda K et al. The grading of lymphovascular space invasion in endometrial carcinoma. Cancer 1999 86: 2090 7.
6. Cohn DE, Horowitz NS, Mutch DG et al. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 2002 87: 243 6.
7. Suzuki C, Matsumoto T, Sonoue H, Arakawa A, Furugen Y, Kinoshita K. Prognostic significance of the infiltrative pattern invasion in endometrioid adenocarcinoma of the endometrium. Pathol Int 2003 53: 495 500.
8. Briët JM, Hollema H, Reesink N et al. Lymphvascular space involvement: An independent prognostic factor in endometrial cancer. Gynecol Oncol 2005 96: 799 804.
9. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002 82: 1255 7.
10. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005 46: 396 402.
11. Evangelou E, Kyzas PA, Trikalinos TA. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 2005 18: 1490 7.
12. Urabe A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology 2006 49: 493 7.
13. Van den Eynden GG, Van der Auwera I, Van Laere SJ et al. Distinguishing blood and lymph vessel invasion in breast cancer. A prospective immunohistochemical study. Br J Cancer 2006 94: 1643 9.
14. Amano T, Matsumoto T, Hayashi T et al. Subepithelial extension of squamous cell carcinoma in the esophagus: Histopathological study using D2-40 immunostaining for 108 superficial carcinomas. Pathol Int 2007 57: 759 64.
15. Announcements. FIGO stages, 1988 revision. Gynecol Oncol 1989 35: 125 7.
16. Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in nodal negative breast cancer. Mod Pathol 2007 20: 183 91.